The increasing consumer preference for private healthcare due to declining NHS and primary physician numbers, along with advancements in healthcare technology, are expected to promote the UK’s private GP EHR market growth. However, data security concerns and technical problems could potentially hinder market adoption. An upcoming report from ResearchAndMarkets will detail the forecast for this market from 2023 to 2028.
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
Himanshu Shah, an activist investor and large shareholder of Novavax, whose stock has plummeted over the years, believes the company should cut costs more aggressively,
